HCW Biologics Inc.

NASDAQ: HCWB · Real-Time Price · USD
4.15
-0.19 (-4.38%)
At close: Aug 15, 2025, 3:59 PM
4.25
2.38%
After-hours: Aug 15, 2025, 05:55 PM EDT

HCW Biologics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-24.75M -30.02M -37.33M -38.37M -27.39M -24.99M -19.73M -18.71M -17.91M -14.9M -12.66M -12.84M -12.08M -12.86M -7.63M -6.24M -6.27M
Depreciation & Amortization
1.36M 1.18M 776.43K 925.44K 1.08M 1.14M 1.12M 1.01M 873.92K 717.85K 552.28K 512.06K 527.58K 543.6K 611.7K 613.8K 606.81K
Stock-Based Compensation
1.04M 1.01M 978.21K 965.63K 989.23K 1M 1.03M 1.11M 1.12M 1.12M 1.19M 894.32K 622.98K 362.63K 23.54K 21.88K 21.88K
Other Working Capital
528.98K 775.08K 1.37M 963.24K -5M -5.14M -5.15M -4.92M 1.09M 2.35M -737.19K 40.48M 45.91M 44.39M 44.75M 3.39M -2.46M
Other Non-Cash Items
524.5K -1.87M 3.49M 3.26M 3.26M 5.55M -180.1K -178.84K -153.38K 144.25K 1.67M 1.44M -257.71K -1.01M -2.44M -2.19M -86.34K
Deferred Income Tax
n/a n/a -409.5K -450.13K -561.07K -561.07K -151.57K -110.94K n/a n/a -1.36M -1.36M -1.36M -1.36M n/a n/a n/a
Change in Working Capital
10.23M 13.6M 15.04M 13.32M -2.25M -4.64M -4.5M -2.3M 3.6M 2.49M 585.67K -1.65M -430.72K 1.46M -3.57M -2.59M -3.73M
Operating Cash Flow
-14.14M -14.23M -15.29M -17.95M -22.48M -22.51M -22.41M -19.13M -12.43M -10.39M -9.97M -12.78M -11.08M -10.98M -11.14M -8.77M -9.94M
Capital Expenditures
-131.91K -261.62K -3.86M -4.46M -6.03M -6.2M -2.56M -12.1M -10.55M -10.28M -10.23M -60.45K -47.54K -47.26K -63.8K -164.88K -109.1K
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -4.05K -34.97M -34.97M -34.97M -34.97M n/a n/a
Sales Maturities Of Investments
n/a n/a n/a 10M 10M 10M 18M 24.98M 24.98M 32.98M 24.98M 8M 8M n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a 10M 10M 10M 2M 8.98M 8.98M 16.98M 24.98M -26.97M -26.97M -34.97M -34.97M n/a n/a
Investing Cash Flow
-131.91K -261.62K -3.86M 5.54M 3.97M 3.8M 7.44M 4.89M 6.43M 14.71M 14.75M -27.03M -27.02M -35.02M -35.03M -164.88K -109.1K
Debt Repayment
5.18M 6.91M 6.41M 3.61M 1.69M -29.29K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -2.82M -2.82M -2.82M -2.82M n/a n/a n/a
Other Financial Acitivies
2.27M 4.82M 2.5M 2.49M 2.49M -8.98K -54.66K 6.26M 6.26M 6.26M 6.3M -5.84M -6.66M -6.76M -6.2M 5.81M 6.63M
Financial Cash Flow
11.29M 15.57M 8.93M 6.12M 4.21M -14.53K -39.13K 6.27M 6.27M 6.27M 6.32M 50.18M 49.36M 49.27M 54.81M 10.81M 11.63M
Net Cash Flow
-2.98M 1.08M -10.22M -6.29M -14.31M -18.73M -15M -7.97M 272.58K 10.6M 11.1M 10.37M 11.26M 3.27M 8.64M 1.88M 1.58M
Free Cash Flow
-14.27M -14.49M -19.15M -22.41M -28.51M -28.72M -24.96M -31.23M -22.98M -20.66M -20.2M -12.84M -11.13M -11.02M -11.2M -8.93M -10.05M